Page last updated: 2024-08-22

tiletamine hydrochloride and Nasopharyngeal Neoplasms

tiletamine hydrochloride has been researched along with Nasopharyngeal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chan, AT; Cheng, SH; Ho, Y; Lui, VW; Ng, MH; Tsang, CM; Tsao, SW; Umezawa, K; Wong, EY; Wong, JH	1

Other Studies

1 other study(ies) available for tiletamine hydrochloride and Nasopharyngeal Neoplasms

Article	Year
A small molecule inhibitor of NF-kappaB, dehydroxymethylepoxyquinomicin (DHMEQ), suppresses growth and invasion of nasopharyngeal carcinoma (NPC) cells. Cancer letters, 2010, Jan-01, Volume: 287, Issue:1 Topics: Apoptosis; Benzamides; Cell Division; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclohexanones; G2 Phase; Humans; Intercellular Adhesion Molecule-1; Matrix Metalloproteinase 9; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; NF-kappa B; Vascular Endothelial Growth Factor A	2010

Article

Year

A small molecule inhibitor of NF-kappaB, dehydroxymethylepoxyquinomicin (DHMEQ), suppresses growth and invasion of nasopharyngeal carcinoma (NPC) cells.

Cancer letters, 2010, Jan-01, Volume: 287, Issue:1

Topics: Apoptosis; Benzamides; Cell Division; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclohexanones; G2 Phase; Humans; Intercellular Adhesion Molecule-1; Matrix Metalloproteinase 9; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; NF-kappa B; Vascular Endothelial Growth Factor A

2010